American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$272M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$237M |
| 3 |
Kenvue
KVUE
|
+$236M |
| 4 |
Norfolk Southern
NSC
|
+$219M |
| 5 |
Amazon
AMZN
|
+$173M |
Top Sells
| 1 |
Marvell Technology
MRVL
|
+$230M |
| 2 |
Walt Disney
DIS
|
+$193M |
| 3 |
Advanced Micro Devices
AMD
|
+$165M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
MarketAxess Holdings
MKTX
|
+$148M |
Sector Composition
| 1 | Technology | 23.05% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
World Kinect Corp
WKC
$1.41B
| $4.76M | ﹤0.01% |
212,189
+62,649
| +42% | +$1.41M |
|
1352
Sabesp
SBS
$16B
| $4.74M | ﹤0.01% |
391,258
+50,570
| +15% | +$613K |
|
1353
LendingClub
LC
$1.91B
| $4.74M | ﹤0.01% |
776,505
+193,455
| +33% | +$1.18M |
|
1354
DuPont de Nemours
DD
$32.4B
| $4.74M | ﹤0.01% |
63,497
+4,691
| +8% | +$350K |
|
1355
XP
XP
$9.94B
| $4.73M | ﹤0.01% |
205,247
+195,146
| +1,932% | +$4.5M |
|
|
OBE
1356
Obsidian Energy
OBE
$403M
| $4.72M | ﹤0.01% |
573,237
+92,922
| +19% | +$765K |
|
1357
Sun Life Financial
SLF
$33.2B
| $4.69M | ﹤0.01% |
96,033
+7,745
| +9% | +$378K |
|
1358
Kinder Morgan
KMI
$61.3B
| $4.68M | ﹤0.01% |
282,404
+49,395
| +21% | +$819K |
|
|
NGD
1359
New Gold Inc
NGD
$5.16B
| $4.67M | ﹤0.01% |
5,095,417
+48,886
| +1% | +$44.8K |
|
1360
Hallador Energy
HNRG
$763M
| $4.67M | ﹤0.01% |
323,538
+39,863
| +14% | +$575K |
|
1361
Univest Financial
UVSP
$886M
| $4.62M | ﹤0.01% |
265,738
+34,521
| +15% | +$600K |
|
1362
Green Dot
GDOT
$751M
| $4.59M | ﹤0.01% |
329,704
-42,648
| -11% | -$594K |
|
|
VRNA
1363
Verona Pharma
VRNA
$9.21B
| $4.57M | ﹤0.01% |
+280,126
| New | +$4.57M |
|
1364
Applied Industrial Technologies
AIT
$9.94B
| $4.54M | ﹤0.01% |
29,351
+3,811
| +15% | +$589K |
|
1365
Ameren
AEE
$27.3B
| $4.5M | ﹤0.01% |
60,167
-60,340
| -50% | -$4.52M |
|
|
CNTA
1366
Centessa Pharmaceuticals
CNTA
$2.92B
| $4.5M | ﹤0.01% |
694,885
+23
| +0% | +$149 |
|
1367
Adaptive Biotechnologies
ADPT
$1.92B
| $4.49M | ﹤0.01% |
824,318
+86,478
| +12% | +$471K |
|
1368
Carlyle Group
CG
$24.1B
| $4.49M | ﹤0.01% |
148,883
-50,183
| -25% | -$1.51M |
|
1369
Washington Trust Bancorp
WASH
$573M
| $4.46M | ﹤0.01% |
169,477
+19,730
| +13% | +$519K |
|
1370
Peapack-Gladstone Financial
PGC
$517M
| $4.46M | ﹤0.01% |
173,958
+19,346
| +13% | +$496K |
|
1371
Celldex Therapeutics
CLDX
$1.62B
| $4.43M | ﹤0.01% |
160,860
+23
| +0% | +$633 |
|
1372
Encore Capital Group
ECPG
$1.02B
| $4.41M | ﹤0.01% |
92,390
-88,795
| -49% | -$4.24M |
|
1373
AbCellera Biologics
ABCL
$1.34B
| $4.39M | ﹤0.01% |
954,623
-158,293
| -14% | -$728K |
|
1374
Marcus Corp
MCS
$504M
| $4.38M | ﹤0.01% |
282,259
+25,867
| +10% | +$401K |
|
1375
Amphenol
APH
$145B
| $4.36M | ﹤0.01% |
103,716
+19,984
| +24% | +$839K |
|